Alison Fohner

Alison Fohner

UNVERIFIED PROFILE

Are you Alison Fohner?   Register this Author

Register author
Alison Fohner

Alison Fohner

Publications by authors named "Alison Fohner"

Are you Alison Fohner?   Register this Author

22Publications

353Reads

47Profile Views

Risk Prediction in HeartĀ Failure: New Methods, Old Problems.

JACC Heart Fail 2019 Oct 5. Epub 2019 Oct 5.

Department of Epidemiology, University of Washington, Seattle Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchf.2019.08.015DOI Listing
October 2019

Democratizing Precision Medicine Through Community Engagement.

Clin Pharmacol Ther 2019 Sep 17;106(3):488-490. Epub 2019 Jun 17.

Department of Biomedical and Pharmaceutical Sciences, University of Montana, Missoula, Montana, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cpt.1508DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692197PMC
September 2019

Perspectives From Early Career Investigators Who Are "Staying in the Game" of Precision Public Health Research.

Am J Public Health 2019 Sep;109(9):1186-1187

Caitlin G. Allen is with the Department of Behavioral Sciences and Health Education, Emory University Rollins School of Public Health, Atlanta, GA. Alison E. Fohner is with the Department of Epidemiology, University of Washington, Seattle. Latrice Landry is with Harvard School of Public Health, Cambridge, MA. Jean L. Paul is with the Department of Psychiatry, Psychotherapy and Psychosomatics, Medical University of Innsbruck, Innsbruck, Austria. Samuel G. Smith is with Leeds Institute of Health Sciences, University of Leeds, Leeds, United Kingdom. Erin Turbitt is with the Graduate School of Health, University of Technology Sydney, Ultimo, Australia. Megan C. Roberts is with the Division of Pharmaceutical Outcomes and Policy, University of North Carolina Eshelman School of Pharmacy, Chapel Hill.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2105/AJPH.2019.305199DOI Listing
September 2019

Early career investigators and precision public health.

Lancet 2019 Aug;394(10196):382-383

Division of Pharmaceutical Outcomes and Policy, University of North Carolina, Eshelman School of Pharmacy, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(19)30498-2DOI Listing
August 2019

Assessing clinical heterogeneity in sepsis through treatment patterns and machine learning.

J Am Med Inform Assoc 2019 Jul 17. Epub 2019 Jul 17.

Division of Research, Kaiser Permanente, Oakland, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jamia/ocz106DOI Listing
July 2019

Response to Koeller et al.

Genet Med 2017 12 10;19(12). Epub 2017 Aug 10.

Department of Bioethics and Humanities, School of Medicine, University of Washington, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/gim.2017.117DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720912PMC
December 2017

PharmGKB summary: very important pharmacogene information for ABCG2.

Pharmacogenet Genomics 2017 11;27(11):420-427

Departments of aGenetics bBioengineering, School of Medicine, Stanford University, Stanford cDepartment of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000305DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788016PMC
November 2017

Carnitine palmitoyltransferase 1A P479L and infant death: policy implications of emerging data.

Genet Med 2017 08 26;19(8):851-857. Epub 2017 Jan 26.

Department of Bioethics and Humanities, School of Medicine, University of Washington, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/gim.2016.202DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620101PMC
August 2017

PharmGKB summary: Macrolide antibiotic pathway, pharmacokinetics/pharmacodynamics.

Pharmacogenet Genomics 2017 04;27(4):164-167

Departments of aGenetics bBioengineering, School of Medicine, Stanford University, Stanford, California cDivision of Pharmaceutics, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000270DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346035PMC
April 2017

PharmGKB summary: ivacaftor pathway, pharmacokinetics/pharmacodynamics.

Pharmacogenet Genomics 2017 01;27(1):39-42

Departments of aGenetics bBioengineering, Stanford University, Stanford, California cDepartment of Pediatrics, Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, Ohio, USA dGenomics England, Queen Mary University of London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000246DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5140711PMC
January 2017

The CYP2C19 Intron 2 Branch Point SNP is the Ancestral Polymorphism Contributing to the Poor Metabolizer Phenotype in Livers with CYP2C19*35 and CYP2C19*2 Alleles.

Drug Metab Dispos 2015 Aug 28;43(8):1226-35. Epub 2015 May 28.

Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee (A.S.C., E.G.S.); Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, Washington (B.P., Y.S., A.F., K.E.T.); Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, Tennessee (D.F., Y.F., S.W., G.W.); Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Stockholm, Sweden (E.A.); and Section of Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden (S.C.S.)

View Article

Download full-text PDF

Source
http://dmd.aspetjournals.org/cgi/doi/10.1124/dmd.115.064428
Publisher Site
http://dx.doi.org/10.1124/dmd.115.064428DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518065PMC
August 2015

Selective deregulation in chemokine signaling pathways of CD4+CD25(hi)CD127(lo)/(-) regulatory T cells in human allergic asthma.

J Allergy Clin Immunol 2009 Apr 18;123(4):933-9.e10. Epub 2009 Jan 18.

Department of Pediatrics, Stanford University, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaci.2008.11.037DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4214553PMC
April 2009

XCL1 enhances regulatory activities of CD4+ CD25(high) CD127(low/-) T cells in human allergic asthma.

J Immunol 2008 Oct;181(8):5386-95

Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2674584PMC
http://dx.doi.org/10.4049/jimmunol.181.8.5386DOI Listing
October 2008